Daily Crunch: Raba Partnership leads $2.1M seed round for African fintech startup Thepeer
Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
Read moreHello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
Read moreIn a downturn, non-dilutive grants or contracts from the government should be seen as more appealing than ever because they provide runway without...
Read moreAuxilius aims to help biotechs manage the financial aspects of the clinical trial process.
Read moreFelix WIlliams is the founder and managing director of Lagomaj Capital. Since starting the St. Louis, Missouri-based venture capital firm soon after...
Read moreInsilico focused exclusively on drug discovery until 2019 when it began developing its own therapeutics.
Read moreColorifix stands out for its progress in using microbes to naturally deposit dyes directly onto fabrics.
Read moreHumble Bee Bio is on a mission to create a biodegradable alternative to plastics by synthesizing the biology of bees. While the New Zealand-based...
Read moreCultivated meat, grown in a bioreactor rather than out on the range, might be one of the big food trends of the decade. But it’s relying on...
Read morePlanetary aims to bring all of the alternative protein production planets into orbit with its scaling technology.
Read moreWhen the topic of fertility comes up, we often hear hushed tones discussing someone else’s or their own journey through infertility.
Read moreWe believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
Read moreA startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which...
Read moreChina is allowing the public to take COVID-19 rapid antigen self-tests for the first time as infection numbers hit a two-year high in recent days....
Read moreIn the past year, there’s been a lot of hype around biomanufacturing — from growing cell-based meat to microbe-powered medicine...
Read moreThe world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug...
Read moreCellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR...
Read moreThe company touts its Fine Mycelium process as the only mycelium engineered to be made-to-order and made-to-specification.
Read moreTech is an increasingly important part of the complex drug discovery and testing process, and with advances in processing power and algorithms it is...
Read moreThe success of CRISPR technology in agriculture has been well documented as a way to manipulate plant genomes to make them more pest and climate...
Read moreWhen COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself...
Read moreAdil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others,...
Read moreLongevica's goal is to validate the pipeline of turning scientific research into consumer-ready products.
Read moreThe drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a...
Read moreEach year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But...
Read moreOn Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies....
Read moreSciFounders, an accelerator program and fund launched back in January with $6 million in backing, has a new proposition for the scientist founders...
Read moreThere are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the...
Read moreThe company has been busy strengthening its supply chain to gear up for scaling its product. Additionally, it hired a head of growth and a community...
Read more